title: [Florid oral papillomatosis: an indication for etretinate?].
abstract: Oral fluoride papillomatosis is a pseudocarcinoma of the mucous membranes, which often creates diagnostic and therapeutic problems. This paper reports oral flouoride papillomatosis in one patient, in whom the tumor mass could preoperatively be reduced by etretinate therapy (200 mg/day).
authors.affiliation: Universitäts-Hautklinik Würzburg.
authors.forename: G
authors.initials: G
authors.lastname: Burg
authors.forename: R
authors.initials: R
authors.lastname: Sobetzko
mesh_terms: D003131:Combined Modality Therapy; D005050:Etretinate / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa / Q000473:pathology; D009062:Mouth Neoplasms / Q000188:drug therapy* / Q000601:surgery; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy* / Q000601:surgery; D010212:Papilloma / Q000188:drug therapy* / Q000601:surgery
chemical_list: D005050:Etretinate
vernacular_title: Floride orale Papillomatose: eine Indikation für Etretinat?